Vaccine News and Research

Latest Vaccine News and Research

Vaccination encouraged for eligible groups as flu cases spike

All those eligible for the flu vaccine are being urged to come forward as the UK Health Security Agency (UKHSA) published data showing a significant increase in the number of recorded flu cases.

15 Dec 2023

New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains

Study introduces a novel dry powder aerosol COVID-19 vaccine, showing its effectiveness in inducing strong immune responses and offering protection against various SARS-CoV-2 strains, including Omicron.

15 Dec 2023

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

15 Dec 2023

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

14 Dec 2023

Study suggests possible targets for the development of a vaccine against multiple sclerosis

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr virus (EBV) is thought to play a role that has not yet been fully clarified.

14 Dec 2023

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

The risk factors associated with CAP caused by serotypes in the different pneumococcal vaccines.

14 Dec 2023

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

Study reveals that COVID-19 vaccination significantly reduces the prevalence of anxiety, insomnia, and depression symptoms among Chinese adults, with vaccinated individuals reporting lower severity of these conditions compared to non-vaccinated individuals.

13 Dec 2023

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows.

13 Dec 2023

Simple trick supercharges T cells to fight stubborn solid tumors

Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells - an approach known as "cell-based therapy," which uses specially designed T cells to fight cancer.

13 Dec 2023

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

13 Dec 2023

U.S. veterans' study reveals key insights into Long COVID and protective role of vaccination

Study examines the clinical characteristics and trends of post-COVID-19 condition (PCC) in U.S. veterans, showing the protective effect of vaccination and the need for precise symptom documentation for effective research and clinical care.

12 Dec 2023

RBD-focused vaccines may offer broader protection against emerging COVID-19 variants

Published in The Lancet's eBioMedicine, 76 healthy adults from Melbourne, aged 18 to 64 who were previously vaccinated with licensed SARS-CoV-2 vaccines, were randomized to receive a fourth dose of a novel protein vaccine, mRNA vaccine or placebo.

12 Dec 2023

Nanoparticle vaccines can help fight zoonotic viral diseases

Announcing a new article publication for Zoonoses journal. Vaccines are the most promising tools for maintaining public health.

12 Dec 2023

Scientists develop new system to display epitopes in mammal cells for immunization studies

A new paper in Biology Methods & Protocols, published by Oxford University Press, indicates that researchers in Germany have developed a new system to display epitopes in mammal cells for immunization studies.

12 Dec 2023

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move that could bolster the continent’s efforts to address historical dependence on imported vaccines and establish its own robust biotechnology sector.

12 Dec 2023

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

From Himedia Laboratories Private Limited 12 Dec 2023

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

Five DNA vaccine candidates based on different SARS-CoV-2 strains.

12 Dec 2023

New optimized vaccine approach targets Hepatitis C virus variability

A method to design vaccines for highly variable viruses like the hepatitis C virus.

12 Dec 2023

New SARS-CoV-2 variant JN.1 shows increased transmissibility and immune resistance

A Japanese study published in BioRxiv explores the virological characteristics of the SARS-CoV-2 JN.1 variant, finding it has a higher effective reproductive number and stronger resistance to immunity from other variants, potentially due to the L455S spike protein mutation.

11 Dec 2023

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

A team of researchers based at the University of Toronto's (U of T) Leslie Dan Faculty of Pharmacy has discovered a novel ionizable lipid nanoparticle that enables muscle-focused mRNA delivery while minimizing off-target delivery to other tissues.

8 Dec 2023

Previous
1
...
44
45
46
47
48
49
50
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Vaccination encouraged for eligible groups as flu cases spike

New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

Study suggests possible targets for the development of a vaccine against multiple sclerosis

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

COVID-19 vaccination eased anxiety, insomnia, and depression in Chinese adults, study finds

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Simple trick supercharges T cells to fight stubborn solid tumors

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

U.S. veterans' study reveals key insights into Long COVID and protective role of vaccination

RBD-focused vaccines may offer broader protection against emerging COVID-19 variants

Nanoparticle vaccines can help fight zoonotic viral diseases

Scientists develop new system to display epitopes in mammal cells for immunization studies

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

New optimized vaccine approach targets Hepatitis C virus variability

New SARS-CoV-2 variant JN.1 shows increased transmissibility and immune resistance

Researchers discover next-gen lipid nanoparticles for muscle-focused mRNA delivery

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in